Effect of inhaled corticosteroids on bronchial hyperresponsiveness in patients with mild asthma.
Asian Pac J Allergy Immunol
;
1995 Dec; 13(2): 81-5
Artículo
en Inglés
| IMSEAR
| ID: sea-36686
ABSTRACT
We studied the effect of inhaled budesonide on bronchial hyperresponsiveness (BHR) in twenty mild asthmatic patients. The study was conducted as a randomized, double-blind, placebo-controlled study. Before entering the study, the patients performed methacholine inhalation challenge (MIC) using a reservoir method to assess BHR. Then, they were randomly allocated to receive budesonide turbuhaler (200 micrograms/dose) or placebo turbuhaler two inhalations, twice daily for eight weeks. During the study, each patient recorded daily asthma score and daily number of puffs of beta 2 agonist and they were assessed at weeks 4 and 8. At the end of the treatment, MIC was repeated again. Patients receiving budesonide showed a significant improvement in airway responsiveness compared with those receiving placebo (p < 0.05). They also showed a significant improvement in asthma severity score and a significant decrease in beta 2 agonist bronchodilator use. This study also suggested that inhaled corticosteroids may be the primary treatment in patients, even with mild asthmatic and well-controlled symptoms.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Pregnenodionas
/
Asma
/
Broncodilatadores
/
Femenino
/
Humanos
/
Masculino
/
Método Doble Ciego
/
Broncoconstrictores
/
Cloruro de Metacolina
/
Hiperreactividad Bronquial
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Revista:
Asian Pac J Allergy Immunol
Año:
1995
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS